SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike stock is facing significant volatility and trending downward after investors reacted negatively to conservative guidance and ongoing concerns about soft sales in China, despite the company posting a double earnings beat. The community is deeply divided, with many retail investors labeling the brand as 'stale' or 'woke' while others view the depressed price as a generational buying opportunity for a long-term turnaround.

Tema ETF Trust - Tema Space Innovators ETF

The newly launched Tema Space Innovators ETF (NASA) is drawing significant attention as traders debate whether its small asset base and exposure to SpaceX represent a promising new momentum play or a potential risk. Community discussion is sharply divided, with some investors eyeing the ticker for its high-volatility potential and similarities to recent thematic ETF surges, while others express skepticism over its low assets under management and limited holdings.

Ganymede

Ganymede is drawing attention as market participants highlight its clean structural formation and consistent buyer interest, fueling community optimism about its potential for growth. Traders are actively discussing the token's quiet momentum and controlled price action, viewing current levels as a favorable accumulation phase.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound (COMP) is seeing intense community debate as investors weigh its status as a battle-tested DeFi protocol against significant price volatility and concerns over governance efficacy. While some holders point to a capped supply and potential for V4 protocol updates as a catalyst for a rebound, many participants are expressing frustration over persistent downward pressure and are actively comparing its performance to competitors like AAVE.

Maul Coin

Maul Coin is trending as the community rallies around a creator-backed project, actively promoting it across social platforms to drive volume and secure a listing. Supporters are focused on organic growth and the potential for a community-led breakout, while closely monitoring market activity following recent whale selling.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors digest the commercial launch of Yartemlea following recent FDA approval and look ahead to upcoming earnings for initial revenue insights. Community discussion remains focused on the company's strong cash position, the strategic potential of the Novo Nordisk partnership, and anticipation of a potential squeeze as market participants weigh long-term value against ongoing short interest.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is currently a focal point for community discussion as investors debate its long-term potential amid significant leadership changes and a shift toward U.S.-based institutional operations. While some users express frustration over stagnant price action and recent market lows, a vocal segment of the community remains focused on the project's real-world utility, recent regulatory clarity, and its ongoing efforts to scale institutional adoption.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as investors weigh recent strategic growth initiatives, including new commercialization partnerships in the metabolic and obesity drug space, against broader concerns regarding patent cliffs and shifting demand in its core vaccine segment. The community is actively discussing the stock's long-term potential as a dividend-paying value play while closely monitoring its oncology pipeline and speculative M&A sentiment within the biotech sector.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc Health is facing heightened scrutiny and volatility ahead of its earnings release, with community sentiment deeply divided between investors betting on a potential short squeeze fueled by deep undervaluation and bears citing concerns over management's compensation, debt, and the 'value trap' narrative. The discourse is dominated by anticipation for the company's path toward profitability, with shareholders actively debating whether recent leadership changes and strategic focus on international growth can trigger a reversal in the long-term downward price trend.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is seeing heightened investor activity as the market reacts to broader biotech M&A trends and positive phase 3 enrollment updates for its obesity pipeline. The community remains focused on the company's potential as a buyout candidate, with long-term holders actively debating the company's competitive positioning against industry giants while navigating short-term market volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

154,336 Shares in UMH Properties, Inc. $UMH Acquired by Wedge Capital Management L L P NC

Wedge Capital Management L L P NC acquired a new stake in UMH Properties, Inc. (NYSE:UMH - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities...

UMH Properties, Inc. (NYSE:UMH) Receives Average Rating of "Moderate Buy" from Analysts

UMH Properties, Inc. (NYSE:UMH - Get Free Report) has been assigned an average rating of "Moderate Buy" from the six research firms that are currently covering the firm, Marketbeat Ratings reports...

UMH Properties, Inc. $UMH Shares Acquired by SG Americas Securities LLC

SG Americas Securities LLC boosted its stake in UMH Properties, Inc. (NYSE:UMH - Free Report) by 629.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,493,476 shares of the real estate investment trust's stock after ac...

TABR Capital Management LLC Buys Shares of 111,350 UMH Properties, Inc. $UMH

TABR Capital Management LLC purchased a new stake in UMH Properties, Inc. (NYSE:UMH - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 111,350 shares of the real estate investment trust's...

UMH Properties (NYSE:UMH) Hits New 52-Week Low  - Here's Why

UMH Properties (NYSE:UMH) Sets New 12-Month Low - Time to Sell...

UMH Properties, Inc. $UMH Holdings Increased by Private Management Group Inc.

Private Management Group Inc. increased its stake in UMH Properties, Inc. (NYSE:UMH - Free Report) by 37.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and...

UMH Properties is Oversold

The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important...

Vanguard Group Inc. Increases Holdings in UMH Properties, Inc. $UMH

Vanguard Group Inc. lifted its holdings in UMH Properties, Inc. (NYSE:UMH - Free Report) by 1.0% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 7,984,615 shares...

First Eagle Investment Management LLC Has $9.96 Million Holdings in UMH Properties, Inc. $UMH

First Eagle Investment Management LLC lifted its stake in shares of UMH Properties, Inc. (NYSE:UMH - Free Report) by 12.9% during the third quarter, according to its most recent filing with the...

William Blair Investment Management LLC Lowers Stake in UMH Properties, Inc. $UMH

William Blair Investment Management LLC cut its stake in UMH Properties, Inc. (NYSE:UMH - Free Report) by 5.7% during the third quarter, according to the company in its most recent Form 13F filing...

UMH Properties, Inc. is a real estate investment trust, which engages in the ownership and operation of manufactured home communities in seven states throughout the northeast. It also leases manufactured homes to residents. It designs accommodate detached, single-family manufactured homes which are produced off-site by manufacturers and installed on sites within the communities. The company was founded by Eugene W. Landy in 1968 and is headquartered in Freehold, NJ.

UMH Properties Inc

Sprott Silver Miners & Physical Silver ETF ($SLVR)

Tradr 2x Long Innovation 100 Monthly ($MQQQ)

GraniteShares Autocallable NVDA ETF ($ANV)

Direxion Daily ASML Bull 2x ($ASMU)

The ultimate tool for the active trader. This award goes to the fund that helped traders master the market—whether by protecting against risks or jumping on the latest trends to capture quick wins.

UMH
UMH Properties Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest UMH News

UMHUMH Properties Inc